BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23523713)

  • 21. Gene symbol: SLC40A1. Disease: primary iron overload.
    Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
    Hum Genet; 2005 Dec; 118(3-4):547. PubMed ID: 16521305
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.
    Funakoshi N; Chaze I; Alary AS; Tachon G; Cunat S; Giansily-Blaizot M; Bismuth M; Larrey D; Pageaux GP; Schved JF; Donnadieu-Rigole H; Blanc P; Aguilar-Martinez P
    Liver Int; 2016 May; 36(5):746-54. PubMed ID: 26474245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and clinical heterogeneity of ferroportin disease.
    Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
    Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man.
    Del-Castillo-Rueda A; Moreno-Carralero MI; Alvarez-Sala-Walther LA; Cuadrado-Grande N; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Eur J Haematol; 2011 Mar; 86(3):260-4. PubMed ID: 21175851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
    Ruivard M
    Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel missense mutation c.470 A>C (p.D157A) in the SLC40A1 gene as a cause of ferroportin disease in a family with hyperferritinaemia.
    Saja K; Bignell P; Robson K; Provan D
    Br J Haematol; 2010 Jun; 149(6):914-6. PubMed ID: 20230395
    [No Abstract]   [Full Text] [Related]  

  • 28. Mild iron overload in an African American man with SLC40A1 D270V.
    Lee PL; Gaasterland T; Barton JC
    Acta Haematol; 2012; 128(1):28-32. PubMed ID: 22584997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).
    Devalia V; Carter K; Walker AP; Perkins SJ; Worwood M; May A; Dooley JS
    Blood; 2002 Jul; 100(2):695-7. PubMed ID: 12091367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease.
    Pietrangelo A; Corradini E; Ferrara F; Vegetti A; De Jong G; Luca Abbati G; Paolo Arcuri P; Martinelli S; Cerofolini E
    Blood Cells Mol Dis; 2006; 37(3):192-6. PubMed ID: 17052926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel human pathological mutations. Gene symbol: SLC40A1. Disease: haemochromatosis, type 4.
    Relvas L; Claro MT; Bento MC; Ribeiro ML
    Hum Genet; 2009 Apr; 125(3):338. PubMed ID: 19309784
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional characterization of a novel SLC40A1 Arg88Ile mutation in a kindred with familial iron overload treated by phlebotomy.
    Womack J; Sukumaran A; Li X; Lozovatsky L; Gallagher PG; Seid JE; Finberg KE
    Blood Cells Mol Dis; 2021 Mar; 87():102532. PubMed ID: 33385755
    [No Abstract]   [Full Text] [Related]  

  • 33. [Usefulness of a diagnostic algorithm hyperferritinemia: A case report of a Spanish family with hereditary hemochromatosis and mutation in SLC40A1 gene].
    Vargas JA; Muñoz A; Samper B; Bornstein B
    Med Clin (Barc); 2015 Jul; 145(1):42-3. PubMed ID: 25441019
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
    Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
    Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective.
    McDonald CJ; Wallace DF; Ostini L; Bell SJ; Demediuk B; Subramaniam VN
    J Hepatol; 2011 Mar; 54(3):538-44. PubMed ID: 21094556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload.
    Beaumont C; Delaunay J; Hetet G; Grandchamp B; de Montalembert M; Tchernia G
    Blood; 2006 May; 107(10):4168-70. PubMed ID: 16439678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
    De Domenico I; McVey Ward D; Nemeth E; Ganz T; Corradini E; Ferrara F; Musci G; Pietrangelo A; Kaplan J
    Haematologica; 2006 Aug; 91(8):1092-5. PubMed ID: 16885049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of the Hepcidin/Ferroportin Regulatory System Causes Pulmonary Iron Overload and Restrictive Lung Disease.
    Neves J; Leitz D; Kraut S; Brandenberger C; Agrawal R; Weissmann N; Mühlfeld C; Mall MA; Altamura S; Muckenthaler MU
    EBioMedicine; 2017 Jun; 20():230-239. PubMed ID: 28499927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.